Does integrating viral hepatitis services into a public STD clinic attract injection drug users for care?

Public Health Reports

Volumn 122, Issue SUPPL. 2, 2007, Pages 31-35

  Hennessy, Robin R ^a   Weisfuse, Isaac B ^a   Schlanger, Karen ^a  

^a NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A VACCINE; HEPATITIS B VACCINE; HEPATITIS C VACCINE; VIRUS ANTIBODY;

ARTICLE; CONTROLLED STUDY; COUNSELING; DOSE RESPONSE; DRUG USE; HEALTH CARE DELIVERY; HEALTH CENTER; HEPATITIS A; HEPATITIS B; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MEDICAL EXAMINATION; MEDICAL EXPERT; MEDICAL RECORD; PATIENT CARE; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; RISK FACTOR; SELF REPORT; SEXUALLY TRANSMITTED DISEASE; VIRUS HEPATITIS; ECONOMICS; ORGANIZATION AND MANAGEMENT; OUTPATIENT DEPARTMENT; PATIENT EDUCATION; PATIENT REFERRAL; PUBLIC HEALTH SERVICE; SUBSTANCE ABUSE; UNITED STATES;

AMBULATORY CARE FACILITIES; COUNSELING; HEPATITIS A VACCINES; HEPATITIS B VACCINES; HEPATITIS, VIRAL, HUMAN; HIV INFECTIONS; HUMANS; NEW YORK CITY; PATIENT EDUCATION; PUBLIC HEALTH PRACTICE; REFERRAL AND CONSULTATION; SEXUALLY TRANSMITTED DISEASES; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 34250362248     PISSN: 00333549     EISSN: 14682877     Source Type: Journal    
DOI: 10.1177/00333549071220s206     Document Type: Article

References (18)

1. Centers for Disease Control and Prevention (US). HIV/AIDS surveillance report, Vol 17. Cases of HIV infection and AIDS in the United States and dependent areas, 2005. Atlanta: Department of Health and Human Services (US), CDC; 2005. Also available from: URL: http://www.cdc.gov/hiv/topics/surveillance/ resources/reports/2005report/pdf/2005SurveillanceReport.pdf [cited 2007 Jan 4].
2. CDC (US). Hepatitis surveillance report No. 61, September 2006. Atlanta: Department of Health and Human Services, CDC; 2006. Also available from: URL: http://www.cdc.gov/ncidod/diseases/hepatitis/resource/PDFs/hep_surveillance_61. pdf [cited 2006 Sep 7].
3. Hwang LY, Ross MW, Zack C, Bull L, Rickman K, Holleman M. Prevalence of sexually transmitted infections and associated risk factors among populations of drug abusers. Clin Infect Dis 2000;31:920-6.
4. Bogart LM, Kral AH, Scott A, Anderson R, Flynn N, Gilbert ML, et al. Sexual risk among injection drug users recruited from syringe exchange programs in California. Sex Transm Dis 2005;32:27-34.
5. Tyndall MW, Patrick D, Spittal P, Li K, O'Shaughnessy MV, Schechter MT. Risky sexual behaviours among injection drug users with high HIV prevalence: implications for STD control. Sex Transm Infect 2002;78(Suppl 1):i170-5.
6. Bradshaw CS, Pierce LI, Tabrizi SN, Fairley CK, Garland SM. Screening injecting drug users for sexually transmitted infections and blood borne viruses using street outreach and self collected sampling. Sex Transm Infect 2005;81:53-8.
7. Ross MW, Gold J, Wodak A, Miller ME. Sexually transmissible diseases in injecting drug users. Genitourin Med 1991;67:32-6.
8. Gunn RA, Murray PJ, Ackers ML, Hardison WG, Margolis HS. Screening for chronic hepatitis B and C virus infections in an urban sexually transmitted disease clinic: rationale for integrating services. Sex Transm Dis 2001;28:166-70.
9. Heinzerling KG, Kral AH, Flynn NM, Anderson RL, Scott A, Gilbert ML, et al. Unmet need for recommended preventive health services among clients of California syringe exchange programs: implications for quality improvement. Drug Alcohol Depend 2006;81:167-78.
10. Carey J, Perlman DC, Friedmann P, Kaplan WM, Nugent A, Deutscher M, et al. Knowledge of hepatitis among active drug injectors at a syringe exchange program. J Subst Abuse Treat 2005;29:47-53.
11. Molitor F, Kuenneth C, Waltermeyer J, Mendoza M, Aguirre A, Brockmann K, et al. Linking HIV-infected persons of color and injection drug users to HIV medical and other services: the California Bridge Project. AIDS Patient Care STDS 2005;19:406-12.
12. Jourden J, Etkind P. Enhancing HIV/AIDS and STD prevention through program integration. Public Health Rep 2004;119:4-11.
13. Gunn RA, Lee MA, Callahan DB, Gonzales P, Murray PJ, Margolis HS. Integrating hepatitis, STD, and HIV services into a drug rehabilitation program. Am J Prev Med 2005;29:27-33.
14. Fox Fields H. The integration of HIV/AIDS, STD, and TB prevention and control programs. Washington (DC): Association of State and Territorial Health Officials; 1998.
15. Campos-Outcalt D, Mickey T, Weisbuch J, Jones R. Integrating routine HIV testing into a public health STD clinic. Public Health Rep 2006;121:175-80.
16. Gunn RA, Murray PJ, Brennan CH, Callahan DB, Alter MJ, Margolis HS. Evaluation of screening criteria to identify persons with hepatitis C virus infection among sexually transmitted disease clinic clients: results from the San Diego Viral Hepatitis Integration Project. Sex Transm Dis 2003;30:340-4.
17. SPSS Inc. SPSS for Windows, Release 11.5.0; Chicago: SPSS Inc.; 2002.
18. Schlanger K, Hennessy RR, Weisfuse IB, Blank S, Dunn A. Evaluation of viral hepatitis services in a New York City STD clinic. Proceedings of the 2002 National STD Prevention Conference; 2002 Mar 4-7; San Diego, CA. (Contact rrhenness@health.nyc.gov for a copy of this presentation.)